18 - 20 June, 2018 | Crowne Plaza Zurich, Zurich, Switzerland

Dieter Moessner

Chairman
German Standards Institute DIN / the European Committee for Standardisation CEN

Dieter is Convenor of CEN/TC 261/SC 5/WG 12 “Marking”. This working group at the European committee for standardisation CEN (www.cen.eu) has created the European standard EN 15823:2010 “Braille on packaging for medicinal products”. It has also created EN 16679:2015 – the European standard on “Tamper verification features for medicinal product packaging”. This European standard specifies requirements and provides guidance for the application, use and check of tamper verification features to the packaging of medicinal products and therefore to comply with the so called “Anti-Manipulation device” of the EU falsified medicines directive.

He is also Convenor of ISO/TC 122/WG 15 “Tamper verification features for medicinal product packaging”. This working group at the International Organization for Standardization has started the creation of ISO 21976, the forthcoming international standard for tamper verification features for medicinal product packaging.

Dieter Mößner is also the chairman of the national German working groups NA 115-03-01 AA “Braille on packaging” and “Tamper verification features for medicinal product packaging”. After six years being the Vice-chairman of the packaging standards committee NAVp (http://www.din.de/en/getting-involved/standards-committees/navp) at the German Standards Institute DIN (www.din.de) he became its Chairman in March 2013.



3:30 PM Anti-counterfeiting and Tamper Evidence Techniques

The European Standard EN 16679 and the International Standard ISO 21976 specify requirements and provides guidance for the application, use and check of tamper verification features to the packaging of medicinal products. Whilst these stringent regulations might seem like a drag, a regulation like the FMD can only bring benefits to the industry.
Counterfeit pharmaceuticals cost the pharma industry an estimated £36.9bn per year, according to research by the World Health Organisation, as well as risking the lives of patients. This workshop has been designed to provide you with the specialist knowledge and skills needed to achieve compliance!

Attend this session to:
  • Decipher exactly which anti-counterfeiting and tamper evident features the EU falsified medicines directive requires
  • Learn about tried and tested techniques for perfecting anti-counterfeiting and tamper evident features in your packaging
  • Get ahead of the steep learning curve by gaining an in-depth understanding of the latest strategies to identify and overcome counterfeited drugs and their effects on the market


Check out the incredible speaker line-up to see who will be joining Dieter.

Download The Latest Agenda